Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern - DocWire News

Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4.ABSTRACTVariants are globally emerging very quickly following pandemic

Signal Transduct Target Ther. 2022 Feb 25;7(1):61. doi: 10.1038/s41392-022-00920-4. ABSTRACT Variants are globally emerging very quickly following pandemic prototypic SARS-CoV-2. To evaluate the cr… [+921 chars]

full article...